-
Myostatin (also
known as
growth differentiation factor 8,
abbreviated GDF8) is a
protein that in
humans is
encoded by the MSTN gene.
Myostatin is a myokine...
-
Myostatin inhibitors are a
class of
drugs that work by
blocking the
effect of
myostatin,
which inhibits muscle growth. In
animal models and
limited human...
-
Myostatin-related
muscle hypertrophy is a rare
genetic condition characterized by
reduced body fat and
increased skeletal muscle size.
Affected individuals...
- double-muscling
phenotype is a
heritable condition caused by a
deletion in the
myostatin gene,
resulting in an
increased number of
muscle fibres (hyperplasia)...
- injury/inflammation in
response to stress) are
increased in
sarcopenic obesity.
Myostatin is also increased. In the fat,
lipotoxicity and
chronic inflammation are...
-
known mutations that
limits and
reduces the
activity of the
myostatin protein. Normally,
myostatin limits the
number of
muscle fibers present at birth, and...
- the term
myokine first occurred in 2003. In 2008, the
first myokine,
myostatin, was identified. The gp130
receptor cytokine IL-6 (Interleukin 6) was...
- PMIDĀ 23995658. Lee SJ,
Gharbi A, Shin JE, Jung ID, Park YM (March 2021). "
Myostatin inhibitor YK11 as a
preventative health supplement for
bacterial sepsis"...
-
precursor to
myostatin,
which limits the size of
skeletal muscle tissue, as well as
inactive myostatin. It does not bind to
active myostatin,
activin A...
-
Stamulumab (MYO-029) is an
experimental myostatin inhibiting drug
developed by
Wyeth Pharmaceuticals for the
treatment of
muscular dystrophy (MD). Stamulumab...